Objectives: The aim of this study was to investigate the effect of pioglitazone on serum uric acid (UA) levels and several diabetic parameters in drug-naïve subjects with type 2 diabetes mellitus (T2DM).
Patients And Methods: The patients (n = 68) received 7.5-30 mg/day pioglitazone monotherapy.